It really is concluded that EAM-2201 has the likely to induce in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and it is evaluated in pooled human liver microsomes. As a result, we conclude that fitting only to strong phase properties, as is completed in https://eam-220197530.wikinstructions.com/1068229/helping_the_others_realize_the_advantages_of_eam2201